Organization · Venture Capital
Cannage Capital
Cannage Capital is an early-stage venture capital firm based in the United States, focusing on investments in companies developing technologies across the AI stack, including cybersecurity and data-driven health.
Overview
What Cannage Capital does
What Cannage Capital is
Cannage Capital is an early-stage venture capital firm based in the United States, focusing on investments in companies developing technologies across the AI stack, including cybersecurity and data-driven health.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2024
- Approximate age
- About 2 years
- Structured capabilities
- Funder
- Last reviewed
- April 30, 2026
Official channels
Find Cannage Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Cannage Capital as a funder
Investment thesis
Cannage Capital invests in early-stage companies at the intersection of various disciplines, focusing on breakthrough ideas across the AI stack, including semiconductors, software infrastructure, and applications.
Focus narrative
Cannage Capital invests in early-stage companies that are developing technologies across the AI stack. Their investment thesis encompasses a wide range of sectors and stages, emphasizing the intersection of different disciplines to foster breakthrough ideas. The firm is particularly interested in companies that leverage AI for cybersecurity, healthcare, and enterprise operations.
Value beyond capital
Cannage Capital adds value to its portfolio companies by leveraging its expertise in AI and cybersecurity, providing strategic guidance, and facilitating connections within its extensive network. The firm emphasizes a collaborative approach to help founders navigate challenges and scale their businesses effectively.
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Sectors
- Artificial IntelligenceCybersecurityHealthcareBiotech & Life SciencesFintechSaaS & Cloud Software
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Cannage Capital has previously backed notable companies, including: Cruise Automation: Focused on autonomous vehicle technology. Covariant: Specializes in AI for robotics and automation. Human: A technology company focusing on privacy and security. Forter: Provides fraud prevention solutions. JupiterOne: Offers cybersecurity management solutions. Sardine: Works in the financial technology sector. Ginkgo Bioworks: Engages in biotechnology and synthetic biology. Hinge Health: Focuses on digital health solutions for musculoskeletal conditions.
Common questions
What to know about Cannage Capital
Upseed classifies Cannage Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.